StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.73+0.02 (+0.05%)

Close on Nov 18, 2026Market cap $27.98BP/E –Yield –

Roivant Sciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Roivant Sciences's market cap was $30.24B on Nov 11, 2026, against $14.35B a year earlier. Over the last 5 years it ranged from $2.26B to $30.24B, with a median of $8.36B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$30.24B+102.1%
2025Dec 31, 2025$14.97B+72.5%
2024Dec 31, 2024$8.68B-3.5%
2023Dec 29, 2023$8.99B+59.8%
2022Dec 30, 2022$5.63B-18.5%
2021Dec 31, 2021$6.90B–

More Roivant Sciences figures

See a number that looks wrong?